Buffett's Berkshire Hathaway Lowers Stake in Johnson & Johnson (JNJ)
Tweet
Share
E-mailGet Alerts JNJ Hot Sheet
Price: $271.22 +0.20%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2%
Revenue Growth %: +5.7%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2%
Revenue Growth %: +5.7%
Join SI Premium – FREE
Warren Buffett's Berkshire Hathaway lowered its stake in Johnson & Johnson (NYSE: JNJ) from 61.8M shares to 28.6M shares.
Johnson & Johnson has been one of the best performing stocks.
Johnson & Johnson has been one of the best performing stocks.
You May Also Be Interested In
- J&J myeloma drug shows 5-year remission in half of early-line patients
- UBS Reiterates Buy Rating on Johnson & Johnson (JNJ)
- New model-based analysis further supports the potential of TECVAYLI® (teclistamab-cqyv) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) to redefine long-term survival expectations in earl
Create E-mail Alert Related Categories
Insider Trades, Insiders' BlogRelated Entities
Warren BuffettSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
